- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Mirum Pharmaceuticals (NASDAQ:MIRM), Quotes and News Summary
Mirum Pharmaceuticals (NASDAQ: MIRM)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.150 | -0.840 | 0.3100 | ||||
| REV | 15.420M | 17.484M | 2.064M |
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.340 | -1.170 | 0.1700 | ||||
| REV | 8.460M | 12.892M | 4.432M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Mirum Pharmaceuticals Questions & Answers
You can purchase shares of Mirum Pharmaceuticals (NASDAQ: MIRM) through any online brokerage.
Other companies in Mirum Pharmaceuticals’s space includes: Avidity Biosciences (NASDAQ:RNA), Cogent Biosciences (NASDAQ:COGT), Immatics (NASDAQ:IMTX), TG Therapeutics (NASDAQ:TGTX) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
The latest price target for Mirum Pharmaceuticals (NASDAQ: MIRM) was reported by SVB Leerink on Tuesday, May 24, 2022. The analyst firm set a price target for 52.00 expecting MIRM to rise to within 12 months (a possible 76.63% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $29.44 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Mirum Pharmaceuticals.
Mirum Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Mirum Pharmaceuticals.
Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.